Association of interaction between smoking and CYP 2C19*3 polymorphism with coronary artery disease in a uighur population

Clinical and Applied Thrombosis/Hemostasis

Volumn 16, Issue 5, 2010, Pages 579-583

  Yang, Yi Ning ^a   Wang, Xin Lei ^a   Ma, Yi Tong ^a   Xie, Xiang ^a   Fu, Zhen Yan ^a   Li, Xiao Mei ^a   Chen, Bang Dang ^b   Liu, Fen ^b  

^a XINJIANG MEDICAL UNIVERSITY   (China)

^b Xinjiang Key Laboratory of Cardiovascular Disease Research   (China)

Author keywords

Coronary artery disease; Cytochrome P450; Epoxyeicosatrienoic acids; Polymorphism; Smoking

Indexed keywords

CYTOCHROME P450; EPOXYICOSATRIENOIC ACID; GLUCOSE;

ADULT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SMOKING;

ARYL HYDROCARBON HYDROXYLASES; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SMOKING;

EID: 77955869504     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/1076029610364522     Document Type: Article

References (29)

1. Lundell K., Wikvall K. Species-specific and age-dependent bile acid composition: aspects on CYP8B and CYP4A subfamilies in bile acid biosynthesis. Curr Drug Metab. 2008 ; 9 (4). 323-331.
2. Fava C., Montagnana M., Almgren P., et al. The V433M variant of the CYP4F2 is associated with ischemic stroke in male Swedes beyond its effect on blood pressure. Hypertension. 2008 ; 52 (2). 373-380.
3. Node K., Ruan XL, Dai J., et al. Activation of Galpha s mediates induction of tissue-type plasminogen activator gene transcription by epoxyeicosatrienoic acids. J Biol Chem. 2001 ; 276 (19). 15983-15989.
4. Fichtlscherer S., Dimmeler S., Breuer S., Busse R., Zeiher AM, Fleming I. Inhibition of cytochrome P450 2C9 improves endothelium-dependent, nitric oxide-mediated vasodilatation in patients with coronary artery disease. Circulation. 2004 ; 109 (2). 178-183.
5. Ercan B., Ayaz L., Ciçek D., Tamer L. Role of CYP2C9 and CYP2C19 polymorphisms in patients with atherosclerosis. Cell Biochem Funct. 2008 ; 26 (3). 309-313.
6. Imig JD Epoxygenase metabolites. Epithelial and vascular actions. Mol Biotechnol. 2000 ; 16 (3). 233-251.
7. Medhora M., Narayanan J., Harder D., Maier KG Identifying endothelium derived hyperpolarizing factor: recent approaches to assay the role of epoxyeicosatrienoic acids. Jpn J Pharmacol. 2001 ; 86 (4). 369-375.
8. Gauthier KM, Falck JR, Reddy LM, Campbell WB 14, 15-EET analogs: characterization of structural requirements for agonist and antagonist activity in bovine coronary arteries. Pharmacol Res. 2004 ; 49 (6). 515-524.
9. Sun J., Sui X., Bradbury JA, Zeldin DC, Conte MS, Liao JK Inhibition of vascular smooth muscle cell migration by cytochrome P450 epoxygenase-derived eicosanoids. Circ Res. 2002 ; 90 (9). 1020-1027.
10. Ercan B., Ayaz L., Ciçek D., Tamer L. Role of CYP2C9 and CYP2C19 polymorphisms in patients with atherosclerosis. Cell Biochem Funct. 2008 ; 26 (3). 309-313.
11. Manson JE, Tosteson H., Ridker PM, et al. The primary prevention of myocardial infarction. N Engl J Med. 1992 ; 326 (21). 1406-1416.
12. Craig MH, Palomaki GE, Haddow JE Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. Br Med J. 1989 ; 298 (6676). 784-788.
13. Eliasson B., Mero N., Taskinen MR, Smith U. The insulin resistance syndrome and postprandial lipid intolerance in smokers. Atherosclerosis. 1997 ; 129 (1). 79-88.
14. Barua RS, Ambrose JA, Saha DC, Eales-Reynolds LJ Smoking is associated with altered endothelial-derived fibrinolytic and antithrombotic factors, an in vitro demonstration. Circulation. 2002 ; 106 (8). 905-908.
15. Li YH, Chen JH, Tsai WC, et al. Synergistic effect of thrombomodulin promoter -33G/A polymorphism and smoking on the onset of acute myocardial infarction. Thromb Haemost. 2002 ; 87 (1). 86-91.
16. Liu PY, Li YH, Tsai WC, et al. Stromelysin-1 promoter 5A/6A polymorphism is an independent genetic prognostic risk factor and interacts with smoking cessation after index premature myocardial infarction. J Thromb Haemost. 2005 ; 3 (9). 1998-2005.
17. Humphries SE, Marin S., Cooper J., Miller G. Interaction between smoking and the stromelysi-1 (MMP3) gene 5A/6A promoter polymorphism and risk of coronary heart disease in healthy men. Ann Hum Genet. 2002 ; 66 (pt 5-6). 343-352.
18. Ruiz-Narváez EA, Yang Y., Nakanishi Y., Kirchdorfer J., Campos H. APOC3/A5 haplotypes, lipid levels, and risk of myocardial infarction in the Central Valley of Costa Rica. J Lipid Res. 2005 ; 46 (12). 2605-2613.
19. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. J Hypertens. 1999 ; 17 (2). 151-183.
20. World Health Organization Study Group. Diabetes mellitus. WHO Tech Rep Ser. 1985 ; 727 (1). 1-104.
21. Node K., Huo Y., Ruan X., et al. Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science. 1999 ; 285 (5431). 1276-1279.
22. Fang X., Weintraub NL, Oltman CL, et al. Human coronary endothelial cells convert 14,15-EET to a biologically active chain-shortened epoxide. Am J Physiol Heart Circ Physiol. 2002 ; 283 (6). H2306 - H2314.
23. Pinto A., Abraham NG, Mullane KM Arachidonic acid-induced endothelial-dependent relaxations of canine coronary arteries: contribution of a cytochrome P-450-dependent pathway. J Pharmacol Exp Ther. 1987 ; 240 (3). 856-863.
24. Gauthier KM, Falck JR, Reddy LM, Campbell WB 14,15-EET analogs: characterization of structural requirements for agonist and antagonist activity in bovine coronary arteries. Pharmacol Res. 2004 ; 49 (6). 515-524.
25. Sun J., Sui X., Bradbury JA, Zeldin DC, Conte MS, Liao JK Inhibition of vascular smooth muscle cell migration by cytochrome P450 epoxygenase-derived eicosanoids. Circ Res. 2002 ; 90 (9). 1020-1027.
26. Teng JK, Lin LJ, Tsai LM, Kwan CM, Chen JH Acute myocardial infarction in young and very old Chinese adults: clinical and therapeutic implications. Int J Cardiol. 1994 ; 44 (1). 29-36.
27. Ye YN, Liu ES, Shin VY, Wu WK, Luo JC, Cho CH Nicotine promoted colon cancer growth via epidermal growth factor receptor, c-Src, and 5-lipoxygenasemediated signal pathway. J Pharmacol Exp Ther. 2004 ; 308 (1). 66-72.
28. Van Diest MJ, Verbeuren TJ, Herman AG 15-Lipoxygenase metabolites of arachidonic acid evoke contractions and relaxations in isolated canine arteries: role of thromboxane receptors, endothelial cells and cyclooxygenase. J Pharmacol Exp Ther. 1991 ; 256 (1). 194-203.
29. Kurahashi K., Nishihashi T., Trandafir CC, Wang AM, Murakami S., Ji X. Diversity of endothelium-derived vasocontracting factors-arachidonic acid metabolites. Acta Pharmacol Sin. 2003 ; 24 (11). 1065-1069.